Ferroptosis: Promising approach for cancer and cancer immunotherapy

Area of Science:

• Oncology
• Immunology
• Cell Death Research

Background:

• Ferroptosis is a regulated cell death characterized by iron-dependent lipid peroxidation.
• Tumor cells are susceptible to ferroptosis, making it a potential therapeutic target.
• Metabolic and immune factors intricately regulate ferroptosis, influencing cancer progression and treatment response.

Purpose of the Study:

• To review the mechanisms of ferroptosis and its interplay with cancer.
• To explore the relationship between ferroptosis, the tumor immune microenvironment, and immune cells.
• To discuss preclinical advancements in combining ferroptosis-targeted drugs with immunotherapy for cancer treatment.

Main Methods:

• Literature review focusing on ferroptosis mechanisms.
• Analysis of the interaction between ferroptosis and the tumor immune microenvironment.
• Examination of preclinical data on ferroptosis-targeted drugs and immunotherapy combinations.

Main Results:

• Ferroptosis induction can impact tumor growth and immune cell activity.
• The tumor immune microenvironment is significantly influenced by ferroptosis.
• Preclinical studies suggest synergistic effects between ferroptosis-targeting agents and immunotherapy.

Conclusions:

• Ferroptosis represents a promising therapeutic avenue in oncology.
• Understanding the interplay between ferroptosis and immunity is crucial for effective cancer treatment.
• Combined strategies targeting ferroptosis and employing immunotherapy hold significant potential for future cancer therapies.